Understanding the PMOS and MASLD Connection: Early Detection of Fatty Liver Disease Through Functional Medicine
PMOS, Insulin Resistance & Fatty Liver: Detecting MASLD Before Advanced Liver Disease
A patient can live with metabolic dysfunction for years while liver disease progresses quietly in the background. For women with PMOS, formerly PCOS, the connection between insulin resistance, hormonal dysfunction, and fatty liver may be especially important.
This episode is deeply personal. Dr. Ellie Campbell joins Dr. Yousef Elyaman to share the story of her lifelong friend Nancy Hartmann, whose experience with PMOS, diabetes, and advanced liver disease became the catalyst for this conversation.
Together, they explore a critical clinical question:
What clues can help us recognize metabolic liver disease earlier, before fibrosis and cirrhosis become advanced?
WHY THIS EPISODE MATTERS
PMOS is much more than an ovarian condition. The metabolic dysfunction associated with PMOS can extend beyond reproductive symptoms and involve insulin resistance, inflammation, metabolic health, and the liver.
In this episode, Dr. Campbell and Dr. Elyaman connect PMOS, insulin resistance, metabolic dysfunction, oxidative stress, MASLD, and liver fibrosis, while examining practical ways clinicians can identify risk earlier.
The conversation moves from basic laboratory clues to tools such as FIB-4, FibroScan, ELF testing, HOMA-IR, GGT, platelet count, homocysteine, iron studies, thyroid testing, and uric acid, followed by practical strategies for addressing metabolic dysfunction.
WHAT YOU’LL LEARN
• Why the shift from PCOS to Polyendocrine Metabolic Ovarian Syndrome (PMOS) better reflects the systemic metabolic nature of the condition
• How insulin resistance can contribute to androgen excess, hormonal dysfunction, inflammation, and fatty liver
• Why patients with PMOS or diabetes may warrant a lower threshold for evaluating liver health
• What ALT, AST, GGT, platelet count, homocysteine, and the neutrophil-to-lymphocyte ratio may add to the clinical picture
• Why an AST greater than or equal to ALT can deserve a closer look in the appropriate clinical context
• Why GGT may provide additional information about oxidative stress and liver risk even when patients feel well
• How age, AST, ALT, and platelet count are incorporated into the FIB-4 assessment for liver fibrosis
• When clinicians should consider FibroScan, ELF testing, ultrasound, or hepatology referral
• Why iron status, thyroid dysfunction, uric acid, environmental exposures, gut dysbiosis, and bile physiology may also matter when evaluating MASLD
• How HOMA-IR and continuous glucose monitoring can help characterize metabolic dysfunction
• The discussion around myo-inositol and berberine for insulin resistance
• Why Mediterranean-style nutrition, resistance training, cardiovascular exercise, weight reduction when appropriate, sleep, and stress management matter
• The discussion around CoQ10, phosphatidylcholine, GLP-1-based therapies, and individualized treatment strategies
• Why identifying fibrosis changes the clinical pathway and when collaboration with a hepatologist becomes important
GUEST: ELLIE CAMPBELL, DO
Dr. Ellie Campbell is a Functional Medicine physician who is board certified in Family Medicine and Integrative Medicine. She has operated a solo concierge medical practice for more than 20 years and lectures nationally on oral-systemic health and its connections to cardiovascular and whole-body health.
She is the author of The Blood Pressure Blueprint: The Holistic Guide to Defeating Hypertension and host of the Sleep, Sex, and Senility podcast.
Connect with Dr. Campbell
Instagram: @dr.elliecampbell
Website:
https://campbellfamilymedicine.com
Book:
The Blood Pressure Blueprint
Podcast:
Sleep, Sex, and Senility
HOST: YOUSEF ELYAMAN, MD, IFMCP
Dr. Yousef Elyaman is the Founder and Medical Director of Absolute Health, an insurance-based Functional Medicine primary care practice in Ocala, Florida, and the Founder of FMP Essentials, a clinical education platform for Functional Medicine practitioners.
He is board certified in Internal Medicine, is an Institute for Functional Medicine Certified Practitioner (IFMCP), and practices Integrative and Functional Medicine. He serves as teaching faculty for the Institute for Functional Medicine, Medical Director of HumanN, and Medical Director of The Guest House Ocala.
His work focuses on translating Functional Medicine into practical, evidence-informed clinical care, with an emphasis on metabolic health, cardiovascular risk, complex chronic disease, and real-world clinical implementation.
Instagram:
@drelyaman
FMP Essentials:
https://www.fmpessentials.com
CLINICAL TOPICS & RESOURCES MENTIONED
• Polyendocrine Metabolic Ovarian Syndrome (PMOS) / PCOS
• Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
• Insulin resistance and HOMA-IR
• ALT and AST
• GGT
• Homocysteine
• CBC with differential
• Neutrophil-to-lymphocyte ratio
• Platelet count
• FIB-4
• FibroScan
• ELF testing
• Ferritin and iron studies
• Comprehensive thyroid testing
• Uric acid
• Gut dysbiosis and the gut-liver connection
• Environmental exposures
• Continuous glucose monitoring
• Mediterranean-style nutrition
• Resistance and cardiovascular exercise
• Myo-inositol
• Berberine
• CoQ10
• Phosphatidylcholine
• GLP-1-based therapies
THIS EPISODE’S SPONSOR
FMP Essentials is the #1 Resource for Functional Medicine Practitioners.
https://www.fmpessentials.com
For serious practitioners ready to go further, the FMP Essentials Mastermind offers advanced mentorship, practical clinical education, exclusive resources, and a trusted peer network.
Learn more:
https://www.fmpessentials.com/mastermind
GO DEEPER: MASTERING MASLD
Fatty liver disease was one of the first major clinical topics developed inside FMP Essentials.
Practitioners who want to take a deeper dive into the evaluation and Functional Medicine approach to MASLD can explore additional clinical education through FMP Essentials.
https://www.fmpessentials.com
HONORING NANCY HARTMANN’S LEGACY
This episode is dedicated to the memory of Nancy Hartmann.
Nancy’s story reminds us that metabolic liver disease can progress silently and that disease severity is not always fully captured by a single laboratory value or scoring system.
Nancy was evaluated by IU Health and was on the liver transplant list. Her MELD score did not adequately reflect how sick she had become.
Nancy’s husband, Jim Hartmann, has emphasized that the most important goal of sharing her story is awareness: helping patients, families, and healthcare professionals recognize the relationship between metabolic dysfunction, PMOS, and liver disease earlier.
For those wishing to make a tribute gift in Nancy’s memory, her family requested that the IU Foundation Liver Research Fund be listed as the primary memorial option.
IU Foundation – Liver Research Fund
In memory of Nancy Hartmann:
https://tinyurl.com/darfknex
American Liver Foundation Memorial Giving:
https://liverfoundation.org/how-you-can-help/tribute-gift/
Another powerful way to honor Nancy is simply to share this episode with clinicians, patients, and families who may benefit from understanding the PMOS-MASLD connection.
GIVING BACK THROUGH MEDICINE
The episode closes with Dr. Campbell describing the giving model built into her medical practice.
A portion of practice profits is directed toward charitable giving, while scholarship patients can contribute community-service hours in place of traditional payment.
Her model reflects a larger principle behind FMP Essentials: clinical knowledge has its greatest impact when practitioners use it to improve the lives of others.
DON’T JUST LISTEN – TRANSFORM YOUR PRACTICE
• Share This Episode – Send it to a colleague, patient, or friend who should understand the PMOS-MASLD connection
• Leave a Review – Tell us your biggest clinical takeaway
• Subscribe for More – Continue your education through FMP Essentials and the FMP Essentials Mastermind
DISCLAIMERS
Educational Purpose Only – This podcast is for informational and educational purposes only and does not constitute medical advice.
No Doctor-Patient Relationship – Listening to this podcast does not establish a doctor-patient relationship.
Supplement Use Disclaimer – Discussion of supplements is educational and is not intended to diagnose, treat, cure, or prevent disease. Patients should consult an appropriately qualified healthcare professional before starting or changing supplements or treatment.
Professional Responsibility – Healthcare practitioners should use their own professional judgment, training, scope of practice, and the individual clinical circumstances of each patient before applying strategies discussed in this episode.
Liability Disclaimer – The host, guest, and affiliated organizations assume no liability for the use or misuse of information presented in this podcast.
MUSIC CREDIT
“Heroes Approaching - Extended” by tunes2go
The FMP Essentials Show – Where Functional Medicine Meets Mastery
Yousef Elyaman, MD, IFMCP
Author of the upcoming book: Ignite Your Healing Power
www.AbsoluteHealthOcala.com
